Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2003 6
2004 2
2005 4
2006 6
2007 5
2008 6
2009 8
2010 9
2011 7
2012 7
2013 3
2014 9
2015 8
2016 6
2017 15
2018 16
2019 8
2020 14
2021 11
2022 15
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Editorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Among authors: verstuyft c. Therapie. 2017 Apr;72(2):173-174. doi: 10.1016/j.therap.2017.01.004. Epub 2017 Jan 30. Therapie. 2017. PMID: 28238399 No abstract available.
REPLY.
Poli E, Verstuyft C, Guettier C, Duclos Vallée JC. Poli E, et al. Among authors: verstuyft c. Hepatology. 2021 Jun;73(6):2616. doi: 10.1002/hep.31635. Hepatology. 2021. PMID: 33200416 No abstract available.
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Recherche translationnelle : médecine personnalisée, médecine de précision, thérapies ciblées : marketing ou science ?
Marquet P, Longeray PH, Barlesi F; les participants à la table ronde N°1 de Giens XXX :; Ameye V, Augé P, Cazeneuve B, Chatelut E, Diaz I, Diviné M, Froguel P, Goni S, Gueyffier F, Hoog-Labouret N, Mourah S, Morin-Surroca M, Perche O, Perin-Dureau F, Pigeon M, Tisseau A, Verstuyft C. Marquet P, et al. Among authors: verstuyft c. Therapie. 2015 Jan-Feb;70(1):1-10. doi: 10.2515/therapie/2014230. Therapie. 2015. PMID: 27393393 French. No abstract available.
Éditorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Among authors: verstuyft c. Therapie. 2017 Apr;72(2):171-172. doi: 10.1016/j.therap.2016.12.008. Epub 2017 Jan 3. Therapie. 2017. PMID: 28117096 French. No abstract available.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients.
Joly C, Desjardins D, Porcher R, Péré H, Bruneau T, Zhang Q, Bastard P, Cobat A, Resmini L, Lenoir O, Savale L, Lécuroux C, Verstuyft C, Roque-Afonso AM, Veyer D, Baron G, Resche-Rigon M, Ravaud P, Casanova JL, Le Grand R, Hermine O, Tharaux PL, Mariette X. Joly C, et al. Among authors: verstuyft c. Front Immunol. 2023 Nov 21;14:1250214. doi: 10.3389/fimmu.2023.1250214. eCollection 2023. Front Immunol. 2023. PMID: 38077399 Free PMC article.
159 results